- Home
- ENTX vs WFF Comparison
ENTX vs WFF Comparison
Compare ENTX & WFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- WFF
- Stock Information
- Founded
- ENTX 2010
- WFF 1984
- Country
- ENTX Israel
- WFF Malaysia
- Employees
- ENTX N/A
- WFF N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- WFF Miscellaneous manufacturing industries
- Sector
- ENTX Health Care
- WFF Consumer Discretionary
- Exchange
- ENTX Nasdaq
- WFF Nasdaq
- Market Cap
- ENTX 101.3M
- WFF 89.8M
- IPO Year
- ENTX 2018
- WFF 2025
- Fundamental
- Price
- ENTX $2.11
- WFF $4.06
- Analyst Decision
- ENTX Strong Buy
- WFF
- Analyst Count
- ENTX 1
- WFF 0
- Target Price
- ENTX $10.00
- WFF N/A
- AVG Volume (30 Days)
- ENTX 43.0K
- WFF 27.8K
- Earning Date
- ENTX 05-13-2025
- WFF 01-01-0001
- Dividend Yield
- ENTX N/A
- WFF N/A
- EPS Growth
- ENTX N/A
- WFF N/A
- EPS
- ENTX N/A
- WFF 0.00
- Revenue
- ENTX $181,000.00
- WFF $4,572,290.00
- Revenue This Year
- ENTX N/A
- WFF N/A
- Revenue Next Year
- ENTX N/A
- WFF N/A
- P/E Ratio
- ENTX N/A
- WFF $908.77
- Revenue Growth
- ENTX N/A
- WFF N/A
- 52 Week Low
- ENTX $1.41
- WFF $3.20
- 52 Week High
- ENTX $2.79
- WFF $5.52
- Technical
- Relative Strength Index (RSI)
- ENTX 52.23
- WFF N/A
- Support Level
- ENTX $2.08
- WFF N/A
- Resistance Level
- ENTX $2.41
- WFF N/A
- Average True Range (ATR)
- ENTX 0.19
- WFF 0.00
- MACD
- ENTX -0.00
- WFF 0.00
- Stochastic Oscillator
- ENTX 38.16
- WFF 0.00
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.